May 24th, 2022 (Earnings Report)Dear Reader,Our scanners just identified several healthtech stocks that are expected to release earnings starting today, May 25th.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
CureVac
Symbol: CVAC
Recent Price: $$18.45
Average Analyst Price Target: $44.50 (141.19%)
Market Cap: $$3.45B
Last Year's EPS: -$0.62
Consensus EPS Forecast: ―
Expected Earnings Date: May 24 2022
Recent Analyst Action: Zhiqiang Shu, analyst at Berenberg Bank, reiterates coverage on CureVac (CVAC) in the Healthcare sector with a Buy rating and a price target of $ 52 (3 weeks ago).
TipRanks.com also reports that CureVac currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $44.50 . The target pricing ranges from a high forecast of $52.00 down to a low forecast of $37.00. CureVac (CVAC)’s last closing price was $$18.45 which would put the average price target at 141.19% upside.Here are 3rd party ratings for CVAC:
- TipRanks.com: Moderate Buy
- TradingView.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Buy, Top 38% (96 out of 253)
--------------------------------------------------------------------------
Fisher & Paykel Healthcare Corporation Limited
Symbol: FSPKF
Recent Price: $$13.13
Average Analyst Price Target: $25.16 (91.62%)
Market Cap: $$7.58B
Last Year's EPS: $0.27
Consensus EPS Forecast: ―
Expected Earnings Date: Nov 21 2022
Recent Analyst Action: John Deakin-Bell, analyst at Citigroup, reiterates coverage on Fisher & Paykel Healthcare Corporation Limited (FSPKF) in the Healthcare sector with a Buy rating and a price target of n/a (12 hours ago).
TipRanks.com also reports that Fisher & Paykel Healthcare Corporation Limited currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $25.16 . The target pricing ranges from a high forecast of $25.16 down to a low forecast of $25.16. Fisher & Paykel Healthcare Corporation Limited (FSPKF)’s last closing price was $$13.13 which would put the average price target at 91.62% upside.Here are 3rd party ratings for FSPKF:
- TipRanks.com: Strong Buy
- TradingView.com: n/a
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
Quoin Pharmaceuticals
Symbol: QNRX
Recent Price: $$0.64
Average Analyst Price Target: $5.00 (681.37%)
Market Cap: $$5.37M
Last Year's EPS: ―
Consensus EPS Forecast: ―
Expected Earnings Date: May 24 2022
Recent Analyst Action: Aydin Huseynov, analyst at Ladenburg Thalmann & Co., reiterates coverage on Quoin Pharmaceuticals (QNRX) in the Healthcare sector with a Buy rating and a price target of $ 2 (2 weeks ago).
TipRanks.com also reports that Quoin Pharmaceuticals currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $5.00 . The target pricing ranges from a high forecast of $8.00 down to a low forecast of $2.00. Quoin Pharmaceuticals (QNRX)’s last closing price was $$0.64 which would put the average price target at 681.37% upside.Here are 3rd party ratings for QNRX:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
Ayr Wellness
Symbol: AYRWF
Recent Price: $$6.39
Average Analyst Price Target: $30.07 (370.58%)
Market Cap: $$427.07M
Last Year's EPS: -$0.36
Consensus EPS Forecast: -$0.27
Expected Earnings Date: May 25 2022
Recent Analyst Action: Andrew Semple, analyst at Echelon Wealth Partners, reiterates coverage on Ayr Wellness (AYRWF) in the Healthcare sector with a Buy rating and a price target of $ 54.7 (1 month ago).
TipRanks.com also reports that Ayr Wellness currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $30.07 . The target pricing ranges from a high forecast of $54.70 down to a low forecast of $13.30. Ayr Wellness (AYRWF)’s last closing price was $$6.39 which would put the average price target at 370.58% upside.Here are 3rd party ratings for AYRWF:
- TipRanks.com: Strong Buy
- TradingView.com: Neutral
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 30% (177 out of 253)
--------------------------------------------------------------------------
Collplant Holdings
Symbol: CLGN
Recent Price: $$9.01
Average Analyst Price Target: $17.00 (88.68%)
Market Cap: $$99.21M
Last Year's EPS: $0.88
Consensus EPS Forecast: -$0.14
Expected Earnings Date: May 25 2022
Recent Analyst Action: Jason Kolbert, analyst at Dawson James, reiterates coverage on Collplant Holdings (CLGN) in the Healthcare sector with a Buy rating and a price target of $ 17 (2 months ago).
TipRanks.com also reports that Collplant Holdings currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $17.00 . The target pricing ranges from a high forecast of $17.00 down to a low forecast of $17.00. Collplant Holdings (CLGN)’s last closing price was $$9.01 which would put the average price target at 88.68% upside.Here are 3rd party ratings for CLGN:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 38% (96 out of 253)
--------------------------------------------------------------------------
Mednax
Symbol: MD
Recent Price: $$18.27
Average Analyst Price Target: $22.29 (22.00%)
Market Cap: $$1.59B
Last Year's EPS: $0.41
Consensus EPS Forecast: $0.48
Expected Earnings Date: Aug 03 2022
Recent Analyst Action: Whit Mayo, analyst at SVB Securities, reiterates coverage on Mednax (MD) in the Healthcare sector with a Hold rating and a price target of $ 20 (2 weeks ago).
TipRanks.com also reports that Mednax currently has 7 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $22.29 . The target pricing ranges from a high forecast of $30.00 down to a low forecast of $16.00. Mednax (MD)’s last closing price was $$18.27 which would put the average price target at 22.00% upside.Here are 3rd party ratings for MD:
- TipRanks.com: Hold
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 15% (214 out of 253)
--------------------------------------------------------------------------
Patterson Companies
Symbol: PDCO
Recent Price: $$31.25
Average Analyst Price Target: $37.00 (18.40%)
Market Cap: $$3.05B
Last Year's EPS: $0.38
Consensus EPS Forecast: $0.56
Expected Earnings Date: May 25 2022
Recent Analyst Action: A.J. Rice, analyst at Credit Suisse, reiterates coverage on Patterson Companies (PDCO) in the Healthcare sector with a Buy rating and a price target of $ 36 (1 week ago).
TipRanks.com also reports that Patterson Companies currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $37.00 . The target pricing ranges from a high forecast of $41.00 down to a low forecast of $35.00. Patterson Companies (PDCO)’s last closing price was $$31.25 which would put the average price target at 18.40% upside.Here are 3rd party ratings for PDCO:
- TipRanks.com: Moderate Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Bottom 6% (238 out of 253)
--------------------------------------------------------------------------
Taro Pharmaceutical
Symbol: TARO
Recent Price: $$35.83
Average Analyst Price Target: $73.00 (103.74%)
Market Cap: $$1.35B
Last Year's EPS: -$0.78
Consensus EPS Forecast: $0.88
Expected Earnings Date: May 25 2022
Recent Analyst Action: Ram Selvaraju, analyst at H.C. Wainwright, reiterates coverage on Taro Pharmaceutical (TARO) in the Healthcare sector with a Buy rating and a price target of $ 73 (2 months ago).
TipRanks.com also reports that Taro Pharmaceutical currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $73.00 . The target pricing ranges from a high forecast of $73.00 down to a low forecast of $73.00. Taro Pharmaceutical (TARO)’s last closing price was $$35.83 which would put the average price target at 103.74% upside.Here are 3rd party ratings for TARO:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 38% (96 out of 253)
--------------------------------------------------------------------------
To Your Financial Future,
The Editor, HealthTechMovers.com
